JP4703091B2 - Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅに対して免疫原性である複数抗原性ペプチド - Google Patents

Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅに対して免疫原性である複数抗原性ペプチド Download PDF

Info

Publication number
JP4703091B2
JP4703091B2 JP2002509360A JP2002509360A JP4703091B2 JP 4703091 B2 JP4703091 B2 JP 4703091B2 JP 2002509360 A JP2002509360 A JP 2002509360A JP 2002509360 A JP2002509360 A JP 2002509360A JP 4703091 B2 JP4703091 B2 JP 4703091B2
Authority
JP
Japan
Prior art keywords
seq
peptide
immunogenic
psaa
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002509360A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004502782A5 (enExample
JP2004502782A (ja
Inventor
エドウィン ダブリュー． アデス，
スコット イー． ジョンソン，
ダニー エル． ジュー，
ジャクリン エス． サンプソン，
ジョージ エム． カーローン，
Original Assignee
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ，センターズ フォー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/613,092 external-priority patent/US6903184B1/en
Application filed by ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ，センターズ フォー filed Critical ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ，センターズ フォー
Publication of JP2004502782A publication Critical patent/JP2004502782A/ja
Publication of JP2004502782A5 publication Critical patent/JP2004502782A5/ja
Application granted granted Critical
Publication of JP4703091B2 publication Critical patent/JP4703091B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2002509360A 2000-07-10 2001-07-10 Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅに対して免疫原性である複数抗原性ペプチド Expired - Fee Related JP4703091B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/613,092 US6903184B1 (en) 1998-03-02 2000-07-10 Multiple antigenic peptides immunogenic against Streptococcus pneumonia
US09/613,092 2000-07-10
PCT/US2001/021626 WO2002004497A2 (en) 2000-07-10 2001-07-10 Multiple antigenic peptides immunogenic against streptococcus pneumoniae

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010245728A Division JP2011057691A (ja) 2000-07-10 2010-11-01 Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅに対して免疫原性である複数抗原性ペプチド

Publications (3)

Publication Number Publication Date
JP2004502782A JP2004502782A (ja) 2004-01-29
JP2004502782A5 JP2004502782A5 (enExample) 2007-06-14
JP4703091B2 true JP4703091B2 (ja) 2011-06-15

Family

ID=24455832

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002509360A Expired - Fee Related JP4703091B2 (ja) 2000-07-10 2001-07-10 Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅに対して免疫原性である複数抗原性ペプチド
JP2010245728A Withdrawn JP2011057691A (ja) 2000-07-10 2010-11-01 Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅに対して免疫原性である複数抗原性ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010245728A Withdrawn JP2011057691A (ja) 2000-07-10 2010-11-01 Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅに対して免疫原性である複数抗原性ペプチド

Country Status (5)

Country Link
EP (1) EP1301530A2 (enExample)
JP (2) JP4703091B2 (enExample)
AU (2) AU2001271935B2 (enExample)
CA (1) CA2416224C (enExample)
WO (1) WO2002004497A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903184B1 (en) 1998-03-02 2005-06-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Multiple antigenic peptides immunogenic against Streptococcus pneumonia
EP2371843B1 (en) * 2005-05-19 2014-09-17 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
EP3156423B1 (en) 2014-06-11 2025-02-19 Riken Multiplex alloantigenic peptide
JP2018070571A (ja) * 2016-11-04 2018-05-10 国立研究開発法人理化学研究所 免疫誘導剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US5981478A (en) * 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
WO1999040200A1 (en) * 1998-02-03 1999-08-12 Center For Disease Control And Prevention RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
EP1060249A1 (en) * 1998-03-02 2000-12-20 The Government of the United States represented by the Secretary of the Department of Health and Human Services Epitope peptides immunogenic against streptococcus pneumoniae
WO2000039278A2 (en) * 1998-12-31 2000-07-06 The General Hospital Corporation Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules

Also Published As

Publication number Publication date
JP2011057691A (ja) 2011-03-24
CA2416224C (en) 2015-08-25
AU2001271935B2 (en) 2006-09-14
WO2002004497A3 (en) 2002-08-01
WO2002004497A2 (en) 2002-01-17
CA2416224A1 (en) 2002-01-17
AU7193501A (en) 2002-01-21
EP1301530A2 (en) 2003-04-16
JP2004502782A (ja) 2004-01-29

Similar Documents

Publication Publication Date Title
US7045132B2 (en) Streptococcus pneumoniae 37-kDa surface adhesin a protein
US8642048B2 (en) Multiple antigenic peptides immunogenic against Streptococcus pneumonia
KR101078919B1 (ko) 신규한 스트렙토코커스 항원
US8580262B2 (en) Group B Streptococcus antigens
US6426074B1 (en) Group B Streptococcus vaccine
US20030232976A1 (en) Streptococcus antigens
AU2001270381A1 (en) Streptococcus antigens
WO2001098334A2 (en) Streptococcus antigens
WO2001096368A2 (en) Use of coiled-coil structural scaffold to generate structure-specific peptides
JPH0866198A (ja) 肺炎球菌の表面タンパクａのエピトープ領域
JP2011057691A (ja) Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅに対して免疫原性である複数抗原性ペプチド
US20130136760A1 (en) Streptococcus pyogenes antigens and corresponding dna fragments
US7074415B2 (en) Streptococcus antigens
AU758764B2 (en) Epitope peptides immunogenic against (streptococcus pneumoniae)
WO2004020609A9 (en) Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
WO1993010238A1 (en) Pneumococcal fimbrial protein a vaccines
AU2001271935A1 (en) Multiple antigenic peptides immunogenic against streptococcus pneumoniae
AU3638600A (en) Proteinase K resistant surface protein of neisseria meningitidis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070417

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070417

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100312

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100611

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100611

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100702

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101101

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20101228

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110208

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110308

R150 Certificate of patent or registration of utility model

Ref document number: 4703091

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees